Clinical Trial Update: SCOT Registry: Small Cell Lung Cancer Treatment and Outcome

View source ↗

Summary

The SCOT Registry study on small cell lung cancer has completed. It summarizes treatments and patient outcomes from the study sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Small Cell | Status: COMPLETED